BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36792410)

  • 1. Improving lung cancer diagnosis with cancer, fungal, and imaging biomarkers.
    Marmor HN; Kammer MN; Deppen SA; Shipe M; Welty VF; Patel K; Godfrey C; Billatos E; Herman JG; Wilson DO; Kussrow AK; Bornhop DJ; Maldonado F; Chen H; Grogan EL
    J Thorac Cardiovasc Surg; 2023 Sep; 166(3):669-678.e4. PubMed ID: 36792410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving Lung Cancer Diagnosis with CT Radiomics and Serum Histoplasmosis Testing.
    Marmor HN; Deppen SA; Welty V; Kammer MN; Godfrey CM; Patel K; Maldonado F; Chen H; Starnes SL; Wilson DO; Billatos E; Grogan EL
    Cancer Epidemiol Biomarkers Prev; 2023 Mar; 32(3):329-336. PubMed ID: 36535650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving malignancy risk prediction of indeterminate pulmonary nodules with imaging features and biomarkers.
    Marmor HN; Jackson L; Gawel S; Kammer M; Massion PP; Grogan EL; Davis GJ; Deppen SA
    Clin Chim Acta; 2022 Sep; 534():106-114. PubMed ID: 35870539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Biomarkers for the Management of Indeterminate Pulmonary Nodules.
    Kammer MN; Lakhani DA; Balar AB; Antic SL; Kussrow AK; Webster RL; Mahapatra S; Barad U; Shah C; Atwater T; Diergaarde B; Qian J; Kaizer A; New M; Hirsch E; Feser WJ; Strong J; Rioth M; Miller YE; Balagurunathan Y; Rowe DJ; Helmey S; Chen SC; Bauza J; Deppen SA; Sandler K; Maldonado F; Spira A; Billatos E; Schabath MB; Gillies RJ; Wilson DO; Walker RC; Landman B; Chen H; Grogan EL; Barón AE; Bornhop DJ; Massion PP
    Am J Respir Crit Care Med; 2021 Dec; 204(11):1306-1316. PubMed ID: 34464235
    [No Abstract]   [Full Text] [Related]  

  • 5. Accuracy of a Novel Histoplasmosis Enzyme Immunoassay to Evaluate Suspicious Lung Nodules.
    Deppen SA; Massion PP; Blume J; Walker RC; Antic S; Chen H; Durkin MM; Wheat LJ; Grogan EL
    Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):321-326. PubMed ID: 30341097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Thoracic Research Evaluation and Treatment 2.0 Model: A Lung Cancer Prediction Model for Indeterminate Nodules Referred for Specialist Evaluation.
    Godfrey CM; Shipe ME; Welty VF; Maiga AW; Aldrich MC; Montgomery C; Crockett J; Vaszar LT; Regis S; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Maldonado F; Blume JD; Deppen SA; Grogan EL
    Chest; 2023 Nov; 164(5):1305-1314. PubMed ID: 37421973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prediction model based on DNA methylation biomarkers and radiological characteristics for identifying malignant from benign pulmonary nodules.
    Xing W; Sun H; Yan C; Zhao C; Wang D; Li M; Ma J
    BMC Cancer; 2021 Mar; 21(1):263. PubMed ID: 33691657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.
    Liu A; Wang Z; Yang Y; Wang J; Dai X; Wang L; Lu Y; Xue F
    Cancer Commun (Lond); 2020 Jan; 40(1):16-24. PubMed ID: 32125097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of Histoplasmosis Enzyme Immunoassay to Evaluate Suspicious Lung Nodules.
    Shipe ME; Deppen SA; Sullivan S; Kammer M; Starnes SL; Wilson DO; Massion PP; Grogan EL
    Ann Thorac Surg; 2021 Feb; 111(2):416-420. PubMed ID: 32682756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the Accuracy of a Deep Learning Method to Risk Stratify Indeterminate Pulmonary Nodules.
    Massion PP; Antic S; Ather S; Arteta C; Brabec J; Chen H; Declerck J; Dufek D; Hickes W; Kadir T; Kunst J; Landman BA; Munden RF; Novotny P; Peschl H; Pickup LC; Santos C; Smith GT; Talwar A; Gleeson F
    Am J Respir Crit Care Med; 2020 Jul; 202(2):241-249. PubMed ID: 32326730
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal lung cancer prediction convolutional neural network model improves the classification of indeterminate pulmonary nodules.
    Paez R; Kammer MN; Balar A; Lakhani DA; Knight M; Rowe D; Xiao D; Heideman BE; Antic SL; Chen H; Chen SC; Peikert T; Sandler KL; Landman BA; Deppen SA; Grogan EL; Maldonado F
    Sci Rep; 2023 Apr; 13(1):6157. PubMed ID: 37061539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing uncertainty in cancer risk estimation for patients with indeterminate pulmonary nodules using an integrated deep learning model.
    Gao R; Li T; Tang Y; Xu K; Khan M; Kammer M; Antic SL; Deppen S; Huo Y; Lasko TA; Sandler KL; Maldonado F; Landman BA
    Comput Biol Med; 2022 Nov; 150():106113. PubMed ID: 36198225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction.
    Sun Y; Li C; Jin L; Gao P; Zhao W; Ma W; Tan M; Wu W; Duan S; Shan Y; Li M
    Eur Radiol; 2020 Jul; 30(7):3650-3659. PubMed ID: 32162003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Are Indeterminate Pulmonary Nodules at Diagnosis Associated with Survival in Patients with High-Grade Osteosarcoma?
    Tsoi KM; Lowe M; Tsuda Y; Lex JR; Fujiwara T; Almeer G; Gregory J; Stevenson J; Evans SE; Botchu R; Jeys LM
    Clin Orthop Relat Res; 2021 Feb; 479(2):298-308. PubMed ID: 32956141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of non-small cell lung cancer and histoplasmosis pulmonary nodules: insights from radiomics model performance compared with clinician observers.
    Uthoff J; Nagpal P; Sanchez R; Gross TJ; Lee C; Sieren JC
    Transl Lung Cancer Res; 2019 Dec; 8(6):979-988. PubMed ID: 32010576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
    Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
    J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Probability of Lung Cancer in Patients With Incidentally Detected Pulmonary Nodules: Clinical Characteristics and Accuracy of Prediction Models.
    Vachani A; Zheng C; Amy Liu IL; Huang BZ; Osuji TA; Gould MK
    Chest; 2022 Feb; 161(2):562-571. PubMed ID: 34364866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A predictive nomogram for two-year growth of CT-indeterminate small pulmonary nodules.
    Xue LM; Li Y; Zhang Y; Wang SC; Zhang RY; Ye JD; Yu H; Qiang JW
    Eur Radiol; 2022 Apr; 32(4):2672-2682. PubMed ID: 34677668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of circulating genetically abnormal cells to support computed tomography for benign and malignant pulmonary nodules.
    Yang H; Chen H; Zhang G; Li H; Ni R; Yu Y; Zhang Y; Wu Y; Liu H
    BMC Cancer; 2022 Apr; 22(1):382. PubMed ID: 35397524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.